These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

603 related items for PubMed ID: 24222941

  • 21. Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C.
    Trépo E, Pradat P, Potthoff A, Momozawa Y, Quertinmont E, Gustot T, Lemmers A, Berthillon P, Amininejad L, Chevallier M, Schlué J, Kreipe H, Devière J, Manns M, Trépo C, Sninsky J, Wedemeyer H, Franchimont D, Moreno C.
    Hepatology; 2011 Jul; 54(1):60-9. PubMed ID: 21488075
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinoma.
    Valenti L, Motta BM, Soardo G, Iavarone M, Donati B, Sangiovanni A, Carnelutti A, Dongiovanni P, Rametta R, Bertelli C, Facchetti F, Colombo M, Fargion S, Fracanzani AL.
    PLoS One; 2013 Jul; 8(10):e75982. PubMed ID: 24155878
    [Abstract] [Full Text] [Related]

  • 24. Patatin-Like Phospholipase Domain-Containing Protein 3 I148M and Liver Fat and Fibrosis Scores Predict Liver Disease Mortality in the U.S. Population.
    Unalp-Arida A, Ruhl CE.
    Hepatology; 2020 Mar; 71(3):820-834. PubMed ID: 31705824
    [Abstract] [Full Text] [Related]

  • 25. Four-Week Omega-3 Supplementation in Carriers of the Prosteatotic PNPLA3 p.I148M Genetic Variant: An Open-Label Study.
    Kuttner CS, Mancina R, Wagenpfeil G, Lammert F, Stokes CS.
    Lifestyle Genom; 2019 Mar; 12(1-6):10-17. PubMed ID: 31454802
    [Abstract] [Full Text] [Related]

  • 26. Impact of patatin-like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension.
    Mandorfer M, Scheiner B, Stättermayer AF, Schwabl P, Paternostro R, Bauer D, Schaefer B, Zoller H, Peck-Radosavljevic M, Trauner M, Reiberger T, Ferenci P, Ferlitsch A.
    Aliment Pharmacol Ther; 2018 Aug; 48(4):451-459. PubMed ID: 29956823
    [Abstract] [Full Text] [Related]

  • 27. The impact of PNPLA3 (rs738409 C>G) polymorphisms on liver histology and long-term clinical outcome in chronic hepatitis B patients.
    Brouwer WP, van der Meer AJ, Boonstra A, Pas SD, de Knegt RJ, de Man RA, Hansen BE, ten Kate FJ, Janssen HL.
    Liver Int; 2015 Feb; 35(2):438-47. PubMed ID: 25284145
    [Abstract] [Full Text] [Related]

  • 28. PNPLA3 Gene Polymorphism Is Associated With Predisposition to and Severity of Alcoholic Liver Disease.
    Salameh H, Raff E, Erwin A, Seth D, Nischalke HD, Falleti E, Burza MA, Leathert J, Romeo S, Molinaro A, Corradini SG, Toniutto P, Spengler U, Daly A, Day CP, Kuo YF, Singal AK.
    Am J Gastroenterol; 2015 Jun; 110(6):846-56. PubMed ID: 25964223
    [Abstract] [Full Text] [Related]

  • 29. No correlation between PNPLA3 rs738409 genotype and fatty liver and hepatic cirrhosis in Japanese patients with HCV.
    Nakamura M, Kanda T, Nakamoto S, Miyamura T, Jiang X, Wu S, Yokosuka O.
    PLoS One; 2013 Jun; 8(12):e81312. PubMed ID: 24349054
    [Abstract] [Full Text] [Related]

  • 30. PNPLA3, the triacylglycerol synthesis/hydrolysis/storage dilemma, and nonalcoholic fatty liver disease.
    Sookoian S, Pirola CJ.
    World J Gastroenterol; 2012 Nov 14; 18(42):6018-26. PubMed ID: 23155331
    [Abstract] [Full Text] [Related]

  • 31. Synergistic Associations of PNPLA3 I148M Variant, Alcohol Intake, and Obesity With Risk of Cirrhosis, Hepatocellular Carcinoma, and Mortality.
    Kim HS, Xiao X, Byun J, Jun G, DeSantis SM, Chen H, Thrift AP, El-Serag HB, Kanwal F, Amos CI.
    JAMA Netw Open; 2022 Oct 03; 5(10):e2234221. PubMed ID: 36190732
    [Abstract] [Full Text] [Related]

  • 32. The PNPLA3 I148M variant promotes lipid-induced hepatocyte secretion of CXC chemokines establishing a tumorigenic milieu.
    Nischalke HD, Lutz P, Bartok E, Krämer B, Langhans B, Frizler R, Berg T, Hampe J, Buch S, Datz C, Stickel F, Hartmann G, Strassburg CP, Nattermann J, Spengler U.
    J Mol Med (Berl); 2019 Nov 03; 97(11):1589-1600. PubMed ID: 31637480
    [Abstract] [Full Text] [Related]

  • 33. Modulation of the effect of PNPLA3 I148M mutation on steatosis and liver damage by alcohol intake in patients with chronic hepatitis C.
    Valenti L, Colombo M, Fargion S.
    J Hepatol; 2011 Dec 03; 55(6):1470-1; author reply 1471-2. PubMed ID: 22100032
    [No Abstract] [Full Text] [Related]

  • 34. Genetics of alcoholic and nonalcoholic fatty liver disease.
    Anstee QM, Daly AK, Day CP.
    Semin Liver Dis; 2011 May 03; 31(2):128-46. PubMed ID: 21538280
    [Abstract] [Full Text] [Related]

  • 35. Genetic variant I148M in PNPLA3 is associated with the ultrasonography-determined steatosis degree in a Chinese population.
    Li Y, Xing C, Tian Z, Ku HC.
    BMC Med Genet; 2012 Nov 23; 13():113. PubMed ID: 23176674
    [Abstract] [Full Text] [Related]

  • 36. Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice.
    Lindén D, Ahnmark A, Pingitore P, Ciociola E, Ahlstedt I, Andréasson AC, Sasidharan K, Madeyski-Bengtson K, Zurek M, Mancina RM, Lindblom A, Bjursell M, Böttcher G, Ståhlman M, Bohlooly-Y M, Haynes WG, Carlsson B, Graham M, Lee R, Murray S, Valenti L, Bhanot S, Åkerblad P, Romeo S.
    Mol Metab; 2019 Apr 23; 22():49-61. PubMed ID: 30772256
    [Abstract] [Full Text] [Related]

  • 37. Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.
    Kanda T, Goto T, Hirotsu Y, Masuzaki R, Moriyama M, Omata M.
    Int J Mol Sci; 2020 Feb 23; 21(4):. PubMed ID: 32102237
    [Abstract] [Full Text] [Related]

  • 38. Impact of PNPLA3 variants on liver histology of 168 patients with HIV infection and chronic hepatitis C.
    Sagnelli C, Merli M, Uberti-Foppa C, Hasson H, Cirillo G, Grandone A, Salpietro S, Minichini C, Del Giudice EM, Lazzarin A, Sagnelli E, Coppola N.
    Clin Microbiol Infect; 2016 Apr 23; 22(4):372-378. PubMed ID: 26806136
    [Abstract] [Full Text] [Related]

  • 39. I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease.
    Valenti L, Alisi A, Galmozzi E, Bartuli A, Del Menico B, Alterio A, Dongiovanni P, Fargion S, Nobili V.
    Hepatology; 2010 Oct 23; 52(4):1274-80. PubMed ID: 20648474
    [Abstract] [Full Text] [Related]

  • 40. The Genetic Variant I148M in PNPLA3 Is Associated With Increased Hepatic Retinyl-Palmitate Storage in Humans.
    Kovarova M, Königsrainer I, Königsrainer A, Machicao F, Häring HU, Schleicher E, Peter A.
    J Clin Endocrinol Metab; 2015 Dec 23; 100(12):E1568-74. PubMed ID: 26439088
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.